These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9836021)

  • 1. Progressive behavioral response to repeated d-amphetamine challenge: further evidence for sensitization in humans.
    Strakowski SM; Sax KW
    Biol Psychiatry; 1998 Dec; 44(11):1171-7. PubMed ID: 9836021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced response to repeated d-amphetamine challenge: evidence for behavioral sensitization in humans.
    Strakowski SM; Sax KW; Setters MJ; Keck PE
    Biol Psychiatry; 1996 Nov; 40(9):872-80. PubMed ID: 8896773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of enhanced response to repeated d-amphetamine challenge in first-episode psychosis: implications for a sensitization model of psychosis in humans.
    Strakowski SM; Sax KW; Setters MJ; Stanton SP; Keck PE
    Biol Psychiatry; 1997 Nov; 42(9):749-55. PubMed ID: 9347122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced behavioral response to repeated d-amphetamine and personality traits in humans.
    Sax KW; Strakowski SM
    Biol Psychiatry; 1998 Dec; 44(11):1192-5. PubMed ID: 9836024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subjective and behavioral effects of repeated d-amphetamine in humans.
    Wachtel SR; de Wit H
    Behav Pharmacol; 1999 May; 10(3):271-81. PubMed ID: 10780242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human response to repeated low-dose d-amphetamine: evidence for behavioral enhancement and tolerance.
    Strakowski SM; Sax KW; Rosenberg HL; DelBello MP; Adler CM
    Neuropsychopharmacology; 2001 Oct; 25(4):548-54. PubMed ID: 11557168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling sensitization to stimulants in humans: an [11C]raclopride/positron emission tomography study in healthy men.
    Boileau I; Dagher A; Leyton M; Gunn RN; Baker GB; Diksic M; Benkelfat C
    Arch Gen Psychiatry; 2006 Dec; 63(12):1386-95. PubMed ID: 17146013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive and behavioral effects of the coadministration of dextroamphetamine and haloperidol in schizophrenia.
    Goldberg TE; Bigelow LB; Weinberger DR; Daniel DG; Kleinman JE
    Am J Psychiatry; 1991 Jan; 148(1):78-84. PubMed ID: 1984711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stress-induced changes in mood and cortisol release predict mood effects of amphetamine.
    Hamidovic A; Childs E; Conrad M; King A; de Wit H
    Drug Alcohol Depend; 2010 Jun; 109(1-3):175-80. PubMed ID: 20176450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabotropic glutamate type 5 receptor binding availability during dextroamphetamine sensitization in mice and humans.
    Smart K; Nagano-Saito A; Milella MS; Sakae DY; Favier M; Vigneault E; Louie L; Hamilton A; Ferguson SSG; Rosa-Neto P; Narayanan S; El Mestikawy S; Leyton M; Benkelfat C
    J Psychiatry Neurosci; 2021 Jan; 46(1):E1-E13. PubMed ID: 32559027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral and subjective effects of d-amphetamine and modafinil in healthy adults.
    Makris AP; Rush CR; Frederich RC; Taylor AC; Kelly TH
    Exp Clin Psychopharmacol; 2007 Apr; 15(2):123-33. PubMed ID: 17469936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual differences in responses to ethanol and d-amphetamine: a within-subject study.
    Holdstock L; de Wit H
    Alcohol Clin Exp Res; 2001 Apr; 25(4):540-8. PubMed ID: 11329494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers.
    Brauer LH; de Wit H
    Biol Psychiatry; 1996 Jan; 39(1):26-32. PubMed ID: 8719123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alprazolam attenuates the behavioral effects of d-amphetamine in humans.
    Rush CR; Stoops WW; Wagner FP; Hays LR; Glaser PE
    J Clin Psychopharmacol; 2004 Aug; 24(4):410-20. PubMed ID: 15232333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute doses of d-amphetamine and bupropion increase cigarette smoking.
    Cousins MS; Stamat HM; de Wit H
    Psychopharmacology (Berl); 2001 Sep; 157(3):243-53. PubMed ID: 11605079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emotional traits predict individual differences in amphetamine-induced positive mood in healthy volunteers.
    Kirkpatrick MG; Goldenson NI; Kapadia N; Kahler CW; de Wit H; Swift RM; McGeary JE; Sussman S; Leventhal AM
    Psychopharmacology (Berl); 2016 Jan; 233(1):89-97. PubMed ID: 26429791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of d-amphetamine in human models of information processing and inhibitory control.
    Fillmore MT; Kelly TH; Martin CA
    Drug Alcohol Depend; 2005 Feb; 77(2):151-9. PubMed ID: 15664716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reinforcing, subject-rated, performance and physiological effects of methylphenidate and d-amphetamine in stimulant abusing humans.
    Stoops WW; Glaser PE; Fillmore MT; Rush CR
    J Psychopharmacol; 2004 Dec; 18(4):534-43. PubMed ID: 15582920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute hydrocortisone administration does not affect subjective responses to d-amphetamine in humans.
    Wachtel SR; Charnot A; de Wit H
    Psychopharmacology (Berl); 2001 Jan; 153(3):380-8. PubMed ID: 11271411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxazepam does not modulate the behavioral effects of d-amphetamine in humans.
    Lile JA; Stoops WW; Wagner FP; Glaser PE; Rush CR
    Pharmacol Biochem Behav; 2005 Oct; 82(2):270-9. PubMed ID: 16182353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.